[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fkFIxvSx0Zx39tj2wvjp82QLwR02UiIssQcmRDulTPCE":3,"$fhUObsMwDQWu2NkmGDeoSoyUV-Kbrl8lzxHfLkZ9qnZo":241},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},3510,"kohlpharma-gmbh","Kohlpharma GmbH",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/367392-2026","2026-06-11 06:06:45","2026-07-20 02:00:55",35,1768004,"2026-07-08T00:00:00.000Z",[18,38,49,56,64,73,82,89,96,106,113,120,131,141,148,158,165,175,184,193,202,209,216,223,232],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":33,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},480962,151181,"469114-2026","https://ted.europa.eu/de/notice/-/detail/469114-2026","can-standard","2025-08-01T00:00:00.000Z","LOT-0001","Nilotinib (ausgenommen als Dispersion in Apfelmus), ATC L01EA03","kohlpharma GmbH","HRB 63210","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)","DAK-Gesundheit","DE","33600000","2026-07-07T22:00:00.000Z",{"award_id":39,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":42,"award_notice_type":23,"award_date":43,"publication_date":44,"lot_number":25,"contract_title":45,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":46,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},479774,149948,"459153-2026","https://ted.europa.eu/de/notice/-/detail/459153-2026","2024-07-01T00:00:00.000Z","2026-07-03T00:00:00.000Z","Etravirin, ATC J05AG04","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2024 - 30.06.2026","DE-HH","2026-07-02T22:00:00.000Z",{"award_id":50,"tender_id":51,"source_name":10,"source_award_id":52,"source_url":53,"award_notice_type":23,"award_date":43,"publication_date":44,"lot_number":25,"contract_title":54,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":55,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},479825,153042,"460579-2026","https://ted.europa.eu/de/notice/-/detail/460579-2026","Dornase alfa, ATC R05CB13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2024 - 30.06.2026",{"award_id":57,"tender_id":58,"source_name":10,"source_award_id":59,"source_url":60,"award_notice_type":23,"award_date":61,"publication_date":44,"lot_number":25,"contract_title":62,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":63,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},479837,152948,"460626-2026","https://ted.europa.eu/de/notice/-/detail/460626-2026","2025-03-01T00:00:00.000Z","Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027",{"award_id":65,"tender_id":66,"source_name":10,"source_award_id":67,"source_url":68,"award_notice_type":23,"award_date":69,"publication_date":70,"lot_number":25,"contract_title":71,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":72,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},474739,151178,"431583-2026","https://ted.europa.eu/de/notice/-/detail/431583-2026","2024-04-01T00:00:00.000Z","2026-06-24T00:00:00.000Z","Rivaroxaban, ATC B01AF01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":74,"tender_id":75,"source_name":10,"source_award_id":76,"source_url":77,"award_notice_type":23,"award_date":69,"publication_date":78,"lot_number":25,"contract_title":79,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":80,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":81,"tender_deadline_utc":8},427774,144038,"410286-2026","https://ted.europa.eu/de/notice/-/detail/410286-2026","2026-06-16T00:00:00.000Z","Dexamethason (ausschließlich IMP), ATC S01BA01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexamethason (ausschließlich IMP), ATC S01BA01 für die Zeit 01.04.2024 - 31.03.2026","2026-06-15T22:00:00.000Z",{"award_id":83,"tender_id":84,"source_name":10,"source_award_id":85,"source_url":86,"award_notice_type":23,"award_date":69,"publication_date":78,"lot_number":25,"contract_title":87,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":88,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":81,"tender_deadline_utc":8},427788,143623,"410574-2026","https://ted.europa.eu/de/notice/-/detail/410574-2026","Interferon beta-1b, ATC L03AB08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2024 - 31.03.2026",{"award_id":90,"tender_id":91,"source_name":10,"source_award_id":92,"source_url":93,"award_notice_type":23,"award_date":61,"publication_date":78,"lot_number":25,"contract_title":94,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":95,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":81,"tender_deadline_utc":8},469265,144005,"413359-2026","https://ted.europa.eu/de/notice/-/detail/413359-2026","Pegfilgrastim, ATC L03AA13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":97,"tender_id":98,"source_name":10,"source_award_id":99,"source_url":100,"award_notice_type":23,"award_date":101,"publication_date":102,"lot_number":25,"contract_title":103,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":104,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":105,"tender_deadline_utc":8},379976,24858,"367346-2026","https://ted.europa.eu/de/notice/-/detail/367346-2026","2026-01-01T00:00:00.000Z","2026-05-29T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsform DOS), ATC R03AK08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2026 - 31.03.2026","2026-05-28T22:00:00.000Z",{"award_id":107,"tender_id":108,"source_name":10,"source_award_id":109,"source_url":11,"award_notice_type":23,"award_date":110,"publication_date":102,"lot_number":25,"contract_title":111,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":112,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":105,"tender_deadline_utc":8},379982,24791,"367392-2026","2024-06-01T00:00:00.000Z","Bexaroten, ATC L01XF03","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":114,"tender_id":115,"source_name":10,"source_award_id":116,"source_url":117,"award_notice_type":23,"award_date":110,"publication_date":102,"lot_number":25,"contract_title":118,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":119,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":105,"tender_deadline_utc":8},421019,24827,"370542-2026","https://ted.europa.eu/de/notice/-/detail/370542-2026","Tiotropium + Olodaterol, ATC R03AL06","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tiotropium + Olodaterol, ATC R03AL06 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":121,"tender_id":122,"source_name":10,"source_award_id":123,"source_url":124,"award_notice_type":23,"award_date":125,"publication_date":126,"lot_number":25,"contract_title":127,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":128,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":129,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":130,"tender_deadline_utc":8},370271,26607,"316505-2026","https://ted.europa.eu/de/notice/-/detail/316505-2026","2025-01-01T00:00:00.000Z","2026-05-08T00:00:00.000Z","Pyridostigmin (ausgenommen retardierte Darreichungsform), ATC N07AA02",1,"Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pyridostigmin (ausgenommen retardierte Dafo.), ATC N07AA02 für die Zeit 01.01.2025 - 31.12.2026","2026-05-07T22:00:00.000Z",{"award_id":132,"tender_id":133,"source_name":10,"source_award_id":134,"source_url":135,"award_notice_type":23,"award_date":136,"publication_date":137,"lot_number":25,"contract_title":138,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":128,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":139,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":140,"tender_deadline_utc":8},368937,27158,"308503-2026","https://ted.europa.eu/de/notice/-/detail/308503-2026","2024-05-01T00:00:00.000Z","2026-05-06T00:00:00.000Z","Megestrol, ATC L02AB01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Megestrol, ATC L02AB01 für die Zeit 01.05.2024 - 30.04.2026","2026-05-05T22:00:00.000Z",{"award_id":142,"tender_id":143,"source_name":10,"source_award_id":144,"source_url":145,"award_notice_type":23,"award_date":136,"publication_date":137,"lot_number":25,"contract_title":146,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":147,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":140,"tender_deadline_utc":8},369041,26906,"309964-2026","https://ted.europa.eu/de/notice/-/detail/309964-2026","Sofosbuvir und Velpatasvir , ATC J05AP55","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Sofosbuvir und Velpatasvir, ATC J05AP55 für die Zeit 01.05.2024 - 30.04.2026",{"award_id":149,"tender_id":150,"source_name":10,"source_award_id":151,"source_url":152,"award_notice_type":23,"award_date":153,"publication_date":154,"lot_number":25,"contract_title":155,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":156,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":157,"tender_deadline_utc":8},343104,36020,"147007-2026","https://ted.europa.eu/de/notice/-/detail/147007-2026","2024-03-01T00:00:00.000Z","2026-03-03T00:00:00.000Z","Budesonid, ATC A07EA06","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Budesonid, ATC A07EA06 für die Zeit 01.03.2024 - 28.02.2025 (zzgl. Verlängerungsoption 1x12 Monate)","2026-03-02T23:00:00.000Z",{"award_id":159,"tender_id":160,"source_name":10,"source_award_id":161,"source_url":162,"award_notice_type":23,"award_date":153,"publication_date":154,"lot_number":25,"contract_title":163,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":164,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":157,"tender_deadline_utc":8},343837,36133,"148098-2026","https://ted.europa.eu/de/notice/-/detail/148098-2026","Meropenem, ATC J01DH02","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Meropenem, ATC J01DH02 für die Zeit 01.03.2024 - 28.02.2026",{"award_id":166,"tender_id":167,"source_name":10,"source_award_id":168,"source_url":169,"award_notice_type":23,"award_date":170,"publication_date":171,"lot_number":25,"contract_title":172,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":173,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":174,"tender_deadline_utc":8},511768,40148,"70719-2026","https://ted.europa.eu/de/notice/-/detail/70719-2026","2024-02-01T00:00:00.000Z","2026-01-30T00:00:00.000Z","Teriparatid, ATC H05AA02","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Teriparatid, ATC H05AA02 für die Zeit 01.02.2024 - 31.01.2026","2026-01-29T23:00:00.000Z",{"award_id":176,"tender_id":177,"source_name":10,"source_award_id":178,"source_url":179,"award_notice_type":23,"award_date":170,"publication_date":180,"lot_number":25,"contract_title":181,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":182,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":183,"tender_deadline_utc":8},508281,40196,"65166-2026","https://ted.europa.eu/de/notice/-/detail/65166-2026","2026-01-29T00:00:00.000Z","Follitropin alfa, ATC G03GA05","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026","2026-01-28T23:00:00.000Z",{"award_id":185,"tender_id":186,"source_name":10,"source_award_id":187,"source_url":188,"award_notice_type":23,"award_date":189,"publication_date":190,"lot_number":25,"contract_title":103,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":191,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":192,"tender_deadline_utc":8},363910,42393,"26169-2026","https://ted.europa.eu/de/notice/-/detail/26169-2026","2024-01-01T00:00:00.000Z","2026-01-14T00:00:00.000Z","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-13T23:00:00.000Z",{"award_id":194,"tender_id":195,"source_name":10,"source_award_id":196,"source_url":197,"award_notice_type":23,"award_date":189,"publication_date":198,"lot_number":25,"contract_title":199,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":200,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":201,"tender_deadline_utc":8},348889,42588,"18894-2026","https://ted.europa.eu/de/notice/-/detail/18894-2026","2026-01-13T00:00:00.000Z","Maraviroc, ATC J05AX09","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Maraviroc, ATC J05AX09 für die Zeit 01.01.2024 - 31.12.2025","2026-01-12T23:00:00.000Z",{"award_id":203,"tender_id":204,"source_name":10,"source_award_id":205,"source_url":206,"award_notice_type":23,"award_date":189,"publication_date":198,"lot_number":25,"contract_title":207,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":208,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":201,"tender_deadline_utc":8},350042,42472,"19177-2026","https://ted.europa.eu/de/notice/-/detail/19177-2026","Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":210,"tender_id":211,"source_name":10,"source_award_id":212,"source_url":213,"award_notice_type":23,"award_date":189,"publication_date":198,"lot_number":25,"contract_title":214,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":215,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":201,"tender_deadline_utc":8},353521,42574,"20575-2026","https://ted.europa.eu/de/notice/-/detail/20575-2026","Formoterol + Beclometason (ausschließlich Darreichungsformen IHP, INH)","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließl. Dafo. IHP, INH), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":217,"tender_id":218,"source_name":10,"source_award_id":219,"source_url":220,"award_notice_type":23,"award_date":189,"publication_date":198,"lot_number":25,"contract_title":221,"winner_name":7,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":222,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":201,"tender_deadline_utc":8},358126,42515,"21340-2026","https://ted.europa.eu/de/notice/-/detail/21340-2026","Buserelin, ATC L02AE01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Buserelin, ATC L02AE01 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":224,"tender_id":225,"source_name":10,"source_award_id":226,"source_url":227,"award_notice_type":23,"award_date":170,"publication_date":228,"lot_number":25,"contract_title":229,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":230,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":231,"tender_deadline_utc":8},506422,58142,"634636-2025","https://ted.europa.eu/de/notice/-/detail/634636-2025","2025-09-29T00:00:00.000Z","Mesalazin, ATC A07EC02","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Mesalazin, ATC A07EC02 für die Zeit 01.02.2024 - 31.01.2026","2025-09-28T22:00:00.000Z",{"award_id":233,"tender_id":234,"source_name":10,"source_award_id":235,"source_url":236,"award_notice_type":23,"award_date":170,"publication_date":237,"lot_number":25,"contract_title":238,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":239,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":240,"tender_deadline_utc":8},488839,67198,"495360-2025","https://ted.europa.eu/de/notice/-/detail/495360-2025","2025-07-29T00:00:00.000Z","Azelastin + Fluticason, ATC R01AD28","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Azelastin + Fluticason, ATC R01AD28 für die Zeit 01.02.2024 - 31.01.2026","2025-07-28T22:00:00.000Z",{"company_slug":6,"years":242,"award_count":14,"top_buyers":243,"yearly_trend":259},5,[244,249,255],{"buyer_name":34,"buyer_key":245,"award_count":246,"total_value_eur":247,"share_count":248},"dak-gesundheit",26,3,0.743,{"buyer_name":250,"buyer_key":251,"award_count":252,"total_value_eur":253,"share_count":254},"AOK Baden-Württemberg","aok-baden-wuerttemberg",8,1768000,0.229,{"buyer_name":256,"buyer_key":257,"award_count":128,"total_value_eur":128,"share_count":258},"Techniker Krankenkasse","techniker-krankenkasse",0.029,[260,263,265],{"year":261,"award_count":262},2024,7,{"year":264,"award_count":242},2025,{"year":266,"award_count":267},2026,23]